Samanta La Russa
Created 17 November 2014
In developed countries, human cytomegalovirus (CMV) is the major infectious cause of congenital birth defects including microcephaly, mental retardation, sensorineural hearing loss, and intrauterine growth restriction. Nonetheless, because of the potential for teratogenicity and toxic effects, no prenatal therapeutic treatment is currently approved by the Food and Drug Administration for congenital CMV infection. Therefore there is great interest in understanding CMV growth and blocking or altogether preventing CMV infection.
In the “Recent CMV Research” special issue in Viruses, of particular interest to families and caregivers affected by CMV diseases are several papers: addressing prevention of CMV infection of trophoblast cells (Zydek et al., 2014), CMV latency (Sinclair and Reeves, 2013), as well as of CMV lung infections in non-HIV infected children (Restrepo-Gualteros et al., 2014). Our ability to enhance immune responses for controlling CMV infection (Hanley and Bollard, 2014) and new strategies for CMV vaccine development guided by non-human primate studies (Deere and Barry, 2014) are discussed in two excellent reviews. Several articles address the CMV manipulation of the immune system, both innate and adaptive immune responses (Stevenson et al., 2014, Fink et al, 2013, 2014, Raghavan et al., 2014) and of DNA damage responses (E and Kowalik, 2014; Kulkarni and Fortunato, 2014). Please find all the papers in this special issue in the ‘Bibliography’ section.
It is my hope that this special issue provides a valuable resource for the families and investigators in the CMV field. I would like to thank all the colleagues who contributed papers to this Special Issue and invite discussions on these papers. In fact the publisher selected two of the papers from this special issue (Zydek et al., 2014; Deere and Barry, 2014) to highlight in the MDPI Magazine.
Humbert Gonzalez Diaz
Created 9 June 2015
MOL2NET Group: Is a scientific group for discussion of ideas related to the conference
MOL2NET International Conference on Multidisciplinary Sciences,
2015,05-10 Dec., MDPI Sciforum, HQ UPV/EHU, Bizkaia.
The group is expected to serve as discussion group both during the conference and inter-conference periods, to update participants with news about the conference and offer the possibility to the participant to make their FAQS and proposals and interact with the organization committee and other participants.MOL2NET Conference:
Dear Colleagues worldwide, I am glad to invite you to participate in our online conference using our social media.
*Excellent online visibility 70+ papers, committees members/papers authors from 20+ countries (USA, UK, Germany, France, Netherlands, China, India, Brazil, Mexico, etc.) affiliated to 25+ universities, hospitals, and foundations, including Harvard Medical School, Stanford University, UMD Minnesota-Duluth, UNL Nebraska-Lincoln, LUC Chicago, U Reading UK, CNAM Paris, U Paris-Sud France, Chinese Academy of Sciences, U Barcelona, USC Santiago de Compostela, UDC Coruña, UPORTO Portugal., etc., along with UPV/EHU and IKERBASQUE Foundation of Basque Country.
* The scope includes, but is not limited to, Experimental #Chemistry (all branches), #Medicine, #Biomedical #Engineering, #Materials, #Nanosciences, #Statistics, #Data #Analytics, #Computer and #Network #Science. * The conference is Totally Online, no physical presence is needed saving traveling costs. Proceedings will be Published Online, Open Access, Totally and Free of Charges (no cost). We accept both experimental and theoretical works in the areas mentioned.
*We call for short communications of preliminary unpublished results or synopsis, critical discussions, or mini-reviews of previously papers already published with 1-2 pages (including figures, tables, ref, etc.). *DOI numbers of the communications can be generated by the author uploading the paper to his/her own ResearchGate or Figshare profiles or by MDPI editorial.
Prof. Fernando Cossío, President of IKERBASQUE, Basque Foundation for Science.
Prof. Allen B. Reitz, CEO Fox Chase Chemical Diversity Center, Inc., PA, USA.
Editor-in-Chief Current Topics in Medicinal Chemistry,
Prof. Danail Bonchev, Virginia Commonwealth University (VCU), USA.
Prof. James J. Chou, Harvard Medical School, Boston, USA.
Prof. Ernesto Estrada, University of Strathclyde Glasgow, UK.
Prof. Dr. Peter Langer, Universität Rostock, Germany.
Prof. Kuo Chen Chou, Gordon Life Science Institue, Boston, USA.
Prof. Jose María Pitarke, Director CICNanoGune, Gipuzkoa.
Prof. Jesús Jimenez Barbero, Scientific Director CICBiogune, Bizkaia.
Prof. Luis M Liz-Marzán, Scientific Director CICbiomaGUNE, Gipuzkoa.
Prof. Subhash Chandra Basak, University of Minnesota Duluth, MN, USA.
Prof. Victor M. Preciado, Penn Engineering, University of Pennsilvania, USA.
Prof. Roberto I. Vazquez Padron, University of Miami, USA.
Prof. Daniel Graham, Loyola University of Chicago, USA.
Prof. R. Todeschini, University of Milano-Bicocca, Italy.
Prof. Esther Lete, and Prof. Nuria Sotomayor, Department of Organic Chemistry II, University of Basque Country (UPV/EHU), Leioa, Bizkaia.
Prof. Alejandro Pazos, Ph.D., D.M., Chair and Director of Department of Computer Sciences, Faculty of Informatics, University of Coruña (UDC), Coruña, Spain.
Law, Ethics, Biosciences:
Prof CM Romeo Casabona, Director of Law & Human Genome Interuniversity Chair, UPV/EHU - University of Deusto, Bilbao, Bizkaia.
MEMBERS OF HONOUR PDTE. SCIENTIFFIC COMMITTEE
Prof. Sonia Arrasate Gil, Department of Organic Chemistry II, UPV/EHU, Bizkaia.
Prof. Juan Ruso , Faculty of Physics, University of Santiago de Compostela (USC), Spain.
Prof. Natalia Cordeiro , Associate Professor with Habilitation, Theoretical Chemistry Network REQUIMTE / Department of Chemistry and Biochemistry, University of Porto, Portugal.
*See full list: http://sciforum.net/conference/mol2net-1/page/organizers Thank you!!!
CONFERENCE CHAIRMAN: Prof. H. Gonzalez-Diaz, (IKERBASQUE Porf.)
Dpt. Organic Chemistry II, University of Basque Country UPV/EHU, Bizkaia
Created 18 November 2014
Brain metastasis is the stage of cancer resulting from cancer cell colonization of the brain. Brain metastasis represents a compendium of devastating diseases arising from several cancer types since mostly fatal because of the extremely poor prognosis when compared to primary cancers treatment. Furthermore, mechanisms underlying brain metastasis remain largely unknown.
To assess, report, and discuss new discoveries in the biology, pathology and treatment of brain metastasis, we launched the Special Issue "Brain Metastasis" in the International Journal of Molecular Sciences in 2012, having continued it in 2014. Under the leadership of Professor Dario Marchetti (Baylor College of Medicine, Houston, Texas, USA) as our Guest Editor, this Special Issue has attracted a great interest from active researchers and scholars in the field, with 25 published manuscripts at highest scientific level. All papers can be accessed freely online. This open discussion group has been established as a forum to further exchange ideas and challenges facing the field, and to provide comments on "Brain Metastasis".
On behalf of our Guest Editor, Professor Dario Marchetti, we invite you to join and follow this discussion group. All comments, questions, files and information will be openly shared within the online group. We hope that this platform will facilitate further stimulating discussions on this important topic.